Login to Your Account



'Bridge to Future Prescribers'

Long Wait for Data, Galena Buys Drug to Go Commercial

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, March 25, 2013

Galena Biopharma Inc. has a bit of a wait ahead of it. The biotech initiated a Phase III trial testing NeuVax (nelipepimut-S) as an adjuvant breast cancer treatment at the beginning of 2012.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription